Ovarian Cancer Biomarker Testing: BRCA, HRD, PARP Inhibitors and Personalized Treatment

This oncology lesson details Biomarker Testing in Ovarian Cancer with a focused overview of ovarian cancer treatment, cytoreductive surgery, and platinum chemotherapy. The presentation connects BRCA testing, HRD testing, and PARP inhibitors, with practical context for diagnosis, treatment sequencing, expected outcomes, and follow-up. The video is especially relevant to people searching for ovarian cancer treatment, BRCA testing, or HRD testing and wanting a clearer explanation of how oncologists make treatment decisions. Useful for learning how modern cancer care combines imaging, pathology, systemic therapy, surgery, radiation, and supportive care. Treatment plans vary with stage pathology molecular features prior therapy and patient